Diisocyanate Antigen-stimulated Monocyte Chemoattractant Protein-1 Synthesis Has Greater Test Efficiency than Specific Antibodies for Identification of Diisocyanate Asthma
- 15 August 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 166 (4) , 445-450
Abstract
We previously reported that diisocyanate-human serum albumin (DIISO-HSA) stimulated production of monocyte chemoattractant protein-1 (MCP-1) by peripheral blood mononuclear cells is significantly associated with a clinical diagnosis of diisocyanate asthma (DA). Others have reported that antibodies for DIISO-HSA are specific but insensitive markers of DA. This study was performed to evaluate test characteristics of the in vitro MCP-1 assay compared with DIISO-HSA–specific immunoglobulin (Ig) G and IgE in identifying workers with DA. MCP-1 was quantitated in peripheral blood mononuclear cell supernatants 48 hours after incubation with DIISO-HSA antigens. Assay results were compared with outcomes of specific inhalation challenge (SIC) testing. Nineteen of 54 (35%) workers assayed for antibodies and MCP-1 stimulation had SIC-confirmed DA. Mean MCP-1 produced by SIC-positive workers was greater than SIC-negative workers (p ⩽ 0.001). Diagnostic sensitivity, specificity, and test efficiency for specific IgG were 47%, 74%, and 65%, respectively, and for specific IgE were 21%, 89%, and 65%, respectively. Sensitivity, specificity, and test efficiency of the MCP-1 test were 79%, 91%, and 87%, respectively. This study indicates that the MCP-1 stimulation assay has greater sensitivity and specificity than the specific antibody assays in correctly identifying DA.Keywords
This publication has 26 references indexed in Scilit:
- Identification of Human Lung and Skin Proteins Conjugated with Hexamethylene Diisocyanate in Vitro and in VivoAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Isocyanate Medical Surveillance: Respiratory Referrals From a Foam Manufacturing Plant Over a Five-Year PeriodAmerican Journal of Industrial Medicine, 1998
- Diisocyanate antigen–enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-α by peripheral mononuclear cells of workers with occupational asthmaJournal of Allergy and Clinical Immunology, 1998
- Characterization of histamine releasing factors in diisocyanate-induced occupational asthmaToxicology, 1996
- Antigen-Specific Stimulation of Histamine Releasing Factors in Diisocyanate-Induced Occupational AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1994
- The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanatesJournal of Allergy and Clinical Immunology, 1993
- Is the Clinical History a Satisfactory Means of Diagnosing Occupational Asthma?American Review of Respiratory Disease, 1991
- Specific serum antibodies against isocyanates: Association with occupational asthmaJournal of Allergy and Clinical Immunology, 1989
- Diverse Profiles of Immunoreactivity in Toluene Diisocyanate (TDI) AsthmaJournal of Occupational and Environmental Medicine, 1981
- Standardization of inhalation provocation tests: Influence of nebulizer output, particle size, and method of inhalationJournal of Allergy and Clinical Immunology, 1981